Champions Oncology, Inc. services
Research Services & Partnering - Preclinical Testing Platforms
Screen Enrollment
Champions Oncology has created screens that enroll each month in either In vivo, Ex Vivo or In vitro platforms. These screens allow for a significant cost savings compared to running stand-alone studies as well as provide free access to Standard of Care response data and other characterization data for each model. Check back frequently to learn more about each screen and to enroll in any active screens.
Analytical Endpoint Testing
Champions Oncology’s Analytical Testing platforms can be used to gather additional data at the endpoint of a preclinical model or ex vivo assay. Using multiplex cytokine assays with flow cytometry readouts, immune cell cytokine intracellular and extracellular staining upon activation can be assessed. Champions Oncology can also collect tissues from your in vivo studies and evaluate pathological changes throughout the tissue and/or the tumor itself using Immunohistochemistry (IHC) and other plate-based platforms (i.e. Luminex/ELISA platforms).